Access to medicine index 2016

The Access to Medicine Index is an independent initiative that ranks the world's leading pharmaceutical companies according to what they are. The Access to Medicine Index is an independent initiative that ranks the world’s leading pharmaceutical companies according to what . 11/14/ · Access to Medicine Index. The Access to Medicine Index is an independent initiative that ranks the world's leading pharmaceutical companies according to what they are. 14 พ.ย. We analyse research-based pharmaceutical companies on how they make medicines, vaccines and diagnostics more accessible in low- and middle-income countries. Nov 14, · Download this publication Access to Medicine Index The Access to Medicine Index is an independent initiative that ranks the world’s leading pharmaceutical companies according to what they are doing for the millions of people in developing countries who do not have reliable access to medicine. The Access to Medicine Index is an independent initiative that ranks the world’s leading pharmaceutical companies according to what they are doing for the millions of people in developing countries who do not have reliable access to medicine. It finds that GSK, which leads the Index for the fifth time, performs best when it comes to matching its access activities with particular needs within the access to medicine agenda. Access to Medicine Index. Download this publication Access to Medicine Index The Access to Medicine Index is an independent initiative that ranks the world's leading pharmaceutical companies according to what they are doing for the millions of people in developing countries who do not have reliable access to medicine. The Access to Medicine Index is an independent initiative that ranks the world’s leading pharmaceutical companies . Access to Medicine Index - Access to Medicine Foundation. It aims to advance access to medicine in low- and middle-income countries by stimulating and guiding the pharmaceutical industry to play a greater role in. The Access to Medicine Index, published Monday, ranks 20 of the world's largest pharmaceutical companies on their efforts to improve. 14 พ.ย.

  • Published on 14 Nov Share Share x Publication Download this publication Access to Medicine Index The Access to Medicine Index is an independent initiative that ranks the world’s leading pharmaceutical companies according to what they are doing for the millions of people in developing countries who do not have reliable access to medicine.
  • The Access to Medicine Index is an independent initiative that ranks the world’s leading pharmaceutical companies according to what they are doing for the millions of people in developing countries who do not have reliable access to medicine. It finds that GSK, which leads the Index for the fifth time, performs best when it comes to matching its access activities with particular needs within the access to medicine agenda. . Access to Medicine Index - Access to Medicine Foundation. Published on 14 Nov Share Share x Publication Download this publication Access to Medicine Index The Access to Medicine Index is an independent initiative that ranks the world's leading pharmaceutical companies according to what they are doing for the millions of people in developing countries who do not have reliable access to medicine. Progress in making more medicines more available is also seen in the way True . 11/14/ · New online: Access to Medicine Index Patents cover more compounds, more countries. Takeda Pharmaceutical Co., Ltd. AstraZeneca plc. Access to Medicine Index Astellas Pharma Inc. Daiichi Sankyo Co., Ltd. Boehringer Ingelheim GmbH. Johnson & Johnson ranked #2—and here’s why. By Ginny GravesNovember 14, Johnson & Johnson Debuts a Groundbreaking R&D Facility in the San Francisco Bay Area. Johnson & Johnson Secures a Top Spot on the Access to Medicine Index The index looks at companies that do the best job of providing access to medications in developing countries. Globally, 2 billion people still cannot access the medicine they need. The world’s leading pharmaceutical companies have an important role to play in improving this situation. The methodology for the Access to Medicine Index places greater emphasis on company performance. If you are interested in joining or hosting a meeting or event, please contact Suzanne Wolf. Please also contact Suzanne if you would like to be notified as soon as the Index is published. The Access to Medicine Index will be published in November, We are currently setting our schedule for presenting and discussing our findings. 11/14/ · Johnson & Johnson Secures a Top Spot on the Access to Medicine Index The index looks at companies that do the best job of providing access to medications in . Ranks 20 of the world's largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy. Access to. Medicine Index. GSK has today been ranked first in the Access to Medicine Index for the fifth consecutive time, taking a leadership position in research &. Globally, 2 billion people still cannot access the medicine they need. The world's leading pharmaceutical companies have an important role. 29 ต.ค. The methodology for the Access to Medicine Index places greater emphasis on company performance. The Access to Medicine Foundation has published its latest methodology for benchmarking companies’ efforts here. Globally, 2 billion people still cannot access the medicine they need. The world’s leading pharmaceutical companies have an important role to play in improving this situation. By Ginny GravesNovember 14, Johnson & Johnson Debuts a Groundbreaking R&D Facility in the San Francisco Bay Area. Johnson & Johnson Secures a Top Spot on the Access to Medicine Index The index looks at companies that do the best job of providing access to medications in developing countries. Johnson & Johnson ranked #2—and here’s why. The Access to Medicine Index, published Monday, ranks 20 of the world's largest pharmaceutical companies on their efforts to improve access to medicine in low- and middle-income countries. The . The world’s top 20 pharmaceutical companies are now submitting data for the Access to Medicine Index, on the measures they are taking to improve access to medicine. GSK has today been ranked first in the Access to Medicine Index for the fifth consecutive time, taking a leadership position in research &. 14 พ.ย. Following the publication of the Access to Medicine Index, the Foundation team has begun a series of meetings and events to discuss its findings with a range of people and organisations working to improve access to medicine for the poorest. This includes a panel discussion at the FT Pharmaceutical and Biotechnology Conference in London, followed by investor meetings in London, Paris. Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best. Access to Medicine Index. The Access to Medicine Index was published today (November 14), analysing the top 20 research-based pharmaceutical companies. The Access to Medicine Foundation has published its latest methodology for benchmarking companies' efforts here. Globally, 2 billion people still cannot access the medicine they need. The methodology for the Access to Medicine Index places greater emphasis on company performance. The world's leading pharmaceutical companies have an important role to play in improving this situation. The Access to Medicine Foundation, in addition to capturing how broadly across its portfolio and to which countries a company applies tiered. 11/14/ · GSK has topped the Index, which ranks individual companies on their performance across seven categories, each time since its launch in Commenting on the Index, . The Access to Medicine Index was published today (November 14), analysing the top 20 research-based pharmaceutical companies. 16 พ.ย. But will they be accessible to children in LMICs? Analysis from the Access to Medicine Index shows that just 7% of pharmaceutical companies’ R&D is for children under 12, despite significant gaps in paediatric treatment options. Some game-changing medicines are on the horizon. Mar 24, · Analysis: Handful of new children’s meds on the horizon. This includes a panel discussion at the FT Pharmaceutical and Biotechnology Conference in London, followed by investor meetings in London, Paris, Basel and New York. Following the publication of the Access to Medicine Index, the Foundation team has begun a series of meetings and events to discuss its findings with a range of people and organisations working to improve access to medicine for the poorest. By Ginny GravesNovember 14, Johnson & Johnson Debuts a Groundbreaking R&D Facility in the San Francisco Bay Area. Johnson & Johnson Secures a Top Spot on the Access to Medicine Index The index looks at companies that do the best job of providing access to medications in developing countries. Johnson & Johnson ranked #2—and here's why. Every two years, the Access to Medicine Foundation, through its Index, benchmarks the top pharmaceutical companies on activities and initiatives. Access to Medicine Index - A research programme by the Access to. The Index, which used 83 metrics to assess. 19 พ.ย. The Access to Medicines Index has been published by the Access to Medicine Foundation. The Index will explore how companies are shifting from commitment-making to action-taking when it comes to ensuring medicines and vaccines are within the reach of the world’s global poor. The Index is scheduled. The world’s top 20 pharmaceutical companies are now submitting data for the Access to Medicine Index, on the measures they are taking to improve access to medicine.
  • But will they be accessible to children in LMICs? Some game-changing medicines are on the horizon. Analysis: Handful of new children's meds on the horizon. Analysis from the Access to Medicine Index shows that just 7% of pharmaceutical companies' R&D is for children under 12, despite significant gaps in paediatric treatment options.
  • This includes a panel discussion at the FT Pharmaceutical and Biotechnology Conference in London, followed by investor meetings in London, Paris. Following the publication of the Access to Medicine Index, the Foundation team has begun a series of meetings and events to discuss its findings with a range of people and organisations working to improve access to medicine for the poorest. Medicine procurement and the use of flexibilities in the agreement on trade-related aspects of intellectual property rights, Bull. 't Hoen, et al. Our focus is on how the AtM Index, by creating “indicators and rankings,” interacts with other initiatives led by various actors in the governance system of. The Index will explore how companies are shifting from commitment-making to action-taking when it comes to ensuring medicines and vaccines are within the reach of the world’s global poor. The world’s top 20 pharmaceutical companies are now submitting data for the Access to Medicine Index, on the measures they are taking to improve access to medicine. This is testament to everyone at GSK, and our partners, who strive every day to research, develop and deliver innovative medicines and vaccines. Commenting on the Index, GSK CEO Sir Andrew Witty said: "For the last decade, our commitments to widening access to healthcare have been recognized by the Access to Medicine Index. Publication date: 9 March | Report language: EN. Technopolis Group has conducted an evaluation of the Access to Medicine Index, for which an executive. This is testament to everyone at GSK, and our partners, who strive every day to research, develop and deliver innovative medicines and vaccines. GSK has topped the Index, which ranks individual companies on their performance across seven categories, each time since its launch in Commenting on the Index, GSK CEO Sir Andrew Witty said: “For the last decade, our commitments to widening access to healthcare have been recognized by the Access to Medicine Index. The report provides insights into what it takes to become and remain a leader in access to medicine. Every two years, this index ranks the world's 20 largest research-based pharmaceutical companies. The ATM index ranks 20 of the world's largest research-based pharmaceutical companies in how they improve access to medicine, vaccines and diagnostics in.